Abstract
This study examines antibody durability in individuals who received an mRNA SARS-CoV-2 vaccine with prior SARS-CoV-2 infection vs those without infection.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
COVID-19 / diagnosis
-
COVID-19 / immunology*
-
COVID-19 Nucleic Acid Testing
-
COVID-19 Vaccines / administration & dosage
-
COVID-19 Vaccines / immunology*
-
Confidence Intervals
-
Female
-
Health Personnel
-
Humans
-
Immunization, Secondary
-
Immunoglobulin G / blood*
-
Longitudinal Studies
-
Male
-
Middle Aged
-
Spike Glycoprotein, Coronavirus / immunology*
-
Time Factors
Substances
-
COVID-19 Vaccines
-
Immunoglobulin G
-
Spike Glycoprotein, Coronavirus
-
spike protein, SARS-CoV-2